Inovio Pharmaceuticals Inc (NASDAQ:INO)
| 1.66 Delayed Data As of Jan 26 |  -0.09 / -5.14%Today’s Change | 1.38 Today|||52-Week Range 4.32 | +6.41% Year-to-Date |
Latest INO News | Press Releases
| First Wave (FWBI) IND Filing Under FDA's Review, Stock Up Jan 16 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 1.75 |
| Today’s open | 1.76 |
| Day’s range | 1.64 - 1.78 |
| Volume | 3,126,679 |
| Average volume (3 months) | 5,550,670 |
| Market cap | $421.6M |
Data as of 3:59pm ET, 01/26/2023
Growth & Valuation
| Earnings growth (last year) | -35.56% |
| Earnings growth (this year) | +23.59% |
| Earnings growth (next 5 years) | +25.62% |
| Revenue growth (last year) | -76.05% |
| P/E ratio | NM |
| Price/Sales | 587.16 |
| Price/Book | 0.92 |
Competitors
| ---- | ||
| VNDAVanda Pharmaceutical... | +0.02 | +0.26% |
| HROWHarrow Health Inc | -0.58 | -3.85% |
| STROSutro Biopharma Inc | -0.26 | -3.35% |
Data as of 4:00pm ET, 01/26/2023
Financials
| Next reporting date | March 15, 2023 |
| EPS forecast (this quarter) | -$0.17 |
| Annual revenue (last year) | $1.8M |
| Annual profit (last year) | -$303.7M |
| Net profit margin | -17,109.87% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Plymouth Meeting, Pennsylvania |
Forecasts
